¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase advance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phase advance
    À§»óÀüÁø
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advance
    ÀüÁø, ¾Õ¿Å±è
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • anal-sadistic phase
    Ç×¹®°¡Çбâ
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • circadian-phase intervention
    ÇÏ·çÁÖ±âÀ§»óÁßÀç
  • colostral phase
    ÃÊÀ¯±â, ùÁ¥¼·Ãë±â
  • compression phase
    ¾ÐÃà»ó
  • delayed sleep phase
    ¼ö¸éÀ§»óÁö¿¬
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • depressive phase
    ¿ì¿ï»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advance
    ¾Õ¿Å±è, ÀüÁø
  • luteal phase endometrial biopsy
    Ȳü±âÀڱ󻸷»ý°Ë
  • phase contrast
    À§»ó´ëÁ¶
  • luteal phase defect
    Ȳü±â°á¼Õ
  • phase difference
    À§»óÂ÷
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase
    »ó, ±â, À§»ó
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • latent phase
    ÀáÀç±â , Àẹ±â
  • plateau phase
    ÆíÆò±â, °íÁ¶±â
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • resolution phase
    ÇØ¼Ò±â
  • resting phase
    È޽ıâ
  • solid phase
    °íü»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phase advance
    À§»óÀüÁø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advance
    ÀüÁø, ¾Õ¿Å±è
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • acute phase reactant
    ±Þ¼º±â¹ÝÀÀ¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • anal-sadistic phase
    Ç×¹®°¡Çбâ
  • phase artifact
    À§»óÀΰø¹°
  • phase axis
    ˤȗ̈
  • phase shift artifact
    À§»óº¯À§Àΰø¹°
  • phase wraparound artifact
    À§»óÆ÷ÀåÀΰø¹°
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • circadian-phase intervention
    ÀÏÁÖ±âÀ§»óÁßÀç
  • colostral phase
    ùÁ¥±â, ÃÊÀ¯±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phase advance
    »óÀüÁø(ßÓîñòä)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advance directives
    »çÀü Áöħ
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • DNA synthetic phase
    DNA ÇÕ¼º±â
  • Go phase
    Go±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • anal-sadistic phase
    Ç×¹®-°¡ÇÐ(½Ã)±â
  • arterial phase
    µ¿¸Æ±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phase advance
    »óÀüÁø(ßÓîñòä)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sleep phase advance
    ¼ö¸éÀ§»óÀüÁø
  • advance directives
    »çÀü Áöħ
  • luteal phase progestational phase
    Ȳ(»ö)ü±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • anal-sadistic phase
    Ç×¹®-°¡ÇÐ(½Ã)±â
  • arterial phase
    µ¿¸Æ±â
  • bacterial phase
    ¼¼±Õ»ó(¡­ßÓ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Luteal phase [Progestational phase]
    Ȳ(»ö)ü±â
    [¿¾ ¿ë¾î] Ȳü±â
  • Leptotene phase
    °¡´Â¼¶À¯±â
    [¿¾ ¿ë¾î] ¼¼»ç±â
  • Phase of cornification
    °¢Áú±â
    [¿¾ ¿ë¾î] °¢ÁúÈ­±â
  • Diplotene phase
    °ã¼¶À¯±â
    [¿¾ ¿ë¾î] ¹è»ç±â
  • Pachytene phase
    ±½Àº¼¶À¯±â
    [¿¾ ¿ë¾î] ÈÄ»ç±â
  • Ovogenetic phase
    ³­Àڹ߻ý±â
    [¿¾ ¿ë¾î] ³­Àڹ߻ý±â
  • Follicular phase
    ³­Æ÷±â
    [¿¾ ¿ë¾î] ³­Æ÷±â
  • Bilateral phase
    ´ëαâ
    [¿¾ ¿ë¾î] ¾çÃø»ó
  • Phase of desquamation
    ¹Ú¸®±â
    [¿¾ ¿ë¾î] ¹Ú¸®±â
  • Phase of incornification
    ºñ°¢Áú±â
    [¿¾ ¿ë¾î] ºñ°¢ÁúÈ­±â
  • Unequal phase
    ºñ´ëαâ
    [¿¾ ¿ë¾î] ºÎµî»ó
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
  • Lactiferous phase
    ¼öÀ¯±â
    [¿¾ ¿ë¾î] ¼öÀ¯±â
  • Synaptic phase
    ¿¬Á¢±â
    [¿¾ ¿ë¾î] ¿¬Á¢±â
  • Menstrual phase
    ¿ù°æ±â
    [¿¾ ¿ë¾î] ¿ù°æ±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocytic phase
    ÀûÇ÷±¸³»¹ßÀ°±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aqueous phase separator centrifugation
    ¾×»ó ºÐ¸®Ã¼ ¿ø½ÉºÐ¸® (äûßÒ ÝÂ×îô÷ êÀãýÝÂ×î)
  • carboxylation phase
    Ä«¸£º¹½ÇÈ­(ûù)±â(Ñ¢)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • decline phase
    "°¨Åð±â(Êõ÷ÜÑ¢), (ÔÒ) death phase"
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • exponential phase
    Áö¼ö±â (ò¦â¦Ñ¢)
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
  • immobile phase
    °íÁ¤»ó(ͳïÒßÓ)
  • inductive phase
    À¯µµ±â(ë¯ÓôÑ¢)
  • lag phase
    Áöü½Ã±â(òÀôòãÁÑ¢)
  • lateral phase separation
    Ãø¸é»óºÐ¸®(ö°ØüßÀÝÂ×î)
  • log phase
    log ±â(Ñ¢)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
  • mobile phase
    À̵¿»ó(ì¹ÔÑßÈ)
  • negative phase
    °¨¼Ò±â(Êõá´Ñ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • arterial phase
    µ¿¸Æ±â
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • equilibrium phase
    ÆòÇü±â
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • in phase
    µ¿À§»ó
  • in-phase image
    À§»ó³»¿µ»ó
  • intravoxel phase dispersion
    º¹¼¿³»À§»óÈ®»ê
  • out of phase
    Å»À§»óÀÇ
  • out of phase gradient echo image
    Å»À§»ó°æ»ç¿¡ÄÚ¿µ»ó
  • phase
    ȗ, ˤȗ
  • phase angle
    À§»ó°¢
  • phase artifact
    À§»óÀΰø¹°
  • phase axis
    ˤȗ̈
  • phase cancellation artifact
    À§»ó¸»¼Ò(»ó¼â)Àΰø¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IAD inactivating dose; instructional advance directive; internal absorbed dose
ILP inadequate luteal phase; insufficiency of luteal phase; interstitial laser photocoagulation; interst...
SPIA solid-phase immunoabsorption; solid-phase immunoassay
LPD Luteal Phase Defect
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AD Advance Directive
Phase I phase
S phase synthesis phase
APRF 3/acute phase response factor
SPRIA Solid Phase Radioimmune Assay
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sleep phase advance
    ¼ö¸é À§»ó ÀüÁø
  • Adv. -¿¡ ´ëÇÏ¿©, -¿¡ ¹ÝÇÏ¿©.

    advance

    ÁøÇà, ÀüÀ§ ºÀÇÕÇÏ´Ù
    ÀüÀ§ ºÀÇÕ¼ú, ÀüÀü¼úÀ» ½ÃÇàÇÏ´Ù.
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
    ¹Ì»ý¹° ¹è¾ç ½Ã °©Àڱ⠼ºÀåÀÌ Áõ°¡ÇÏ´Â ½Ã±â.
  • acute phase protein
    ±Þ¼º±â ´Ü¹éÁú
    °¨¿°À̳ª Á¶Á÷ ¼Õ»óÀÌ ÀÖÀ» ¶§ Á¤»óº¸´Ù 2-100¹è Á¤µµ Áõ°¡ÇÏ´Â Ç÷Àå ´Ü¹éÁúÀ» ÃÑĪÇÏ¿© APP¶ó°í ÇÏ¸ç ¼±Ãµ¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
  • acute phase reaction
    ±Þ¼º±â ¹ÝÀÀ
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • anal-sadistic phase
    Ç×¹®-°¡Çбâ, Ç×¹®-°¡ÇÐ ½Ã±â
  • arousal phase
    ÀáÀ» ±ú´Â ½Ã±â
  • arterial phase
    µ¿¸Æ ±â
  • bacterial phase
    ¼¼±Õ »ó
    ¼¼±ÕÀÌ ´«¿¡ º¸ÀÌ´Â ¾ç»ó.
  • closing phase
    Æó±¸ ´Ü°è
  • dispersed phase
    ºÐ»ê »ó
  • equilibrium phase diagram
    ÆòÇü »óŵµ
    ÇÕ±ÝÀÇ Á¶¼º°ú ¿Âµµ°¡ ¹Ù²î¾îÁ³À» ¶§ÀÇ ÆòÇü »óÅ¿¡¼­ÀÇ »óÀÇ º¯È­¸¦ º¸ÀÎ ±×¸².
  • expiratory phase
    È£±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
advance 1. The act of advancing or moving forward or upward; progress.
2. Improvement or progression, physically, mentally, morally, or socially; as, an advance in health, knowledge, or religion; an advance in rank or office.
3. An addition to the price; rise in price or value; as, an advance on the prime cost of goods.
4. The first step towards the attainment of a result; approach made to gain favor, to form an acquaintance, to adjust a difference, etc.; an overture; a tender; an offer; usually in the plural. "[He] made the like advances to the dissenters." (Swift)
5. A furnishing of something before an equivalent is received (as money or goods), towards a capital or stock, or on loan; payment beforehand; the money or goods thus furnished; money or value supplied beforehand. "I shall, with pleasure, make the necessary advances." (Jay) "The account was made up with intent to show what advances had been made." (Kent) In advance In front; before. Beforehand; before an equivalent is received. In the state of having advanced money on account; as, A is advance to B a thousand dollars or pounds.
Origin: Cf. F. Avance, fr. Avancer. See Advance, v.
1. To bring forward; to move towards the van or front; to make to go on.
2. To raise; to elevate. "They . . . Advanced their eyelids." (Shak)
3. To raise to a higher rank; to promote. "Ahasueres . . . Advanced him, and set his seat above all the princes." (Esther III. 1)
4. To accelerate the growth or progress; to further; to forward; to help on; to aid; to heighten; as, to advance the ripening of fruit; to advance one's interests.
5. To bring to view or notice; to offer or propose; to show; as, to advance an argument. "Some ne'er advance a judgment of their own." (Pope)
6. To make earlier, as an event or date; to hasten.
7. To furnish, as money or other value, before it becomes due, or in aid of an enterprise; to supply beforehand; as, a merchant advances money on a contract or on goods consigned to him.
8. To raise to a higher point; to enhance; to raise in rate; as, to advance the price of goods.
9. To extol; to laud. "Greatly advancing his gay chivalry." (Spenser)
Synonym: To raise, elevate, exalt, aggrandize, improve, heighten, accelerate, allege, adduce, assign.
Origin: OE. Avancen, avauncen, F. Avancer, fr. A supposed LL. Abantiare; ab + ante (F. Avant) before. The spelling with d was a mistake, a- being supposed to be fr. L. Ad. See Avaunt.
Source: Websters Dictionary
(01 Mar 1998)
advance directives Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes.
There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions.
Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society).
(12 Mar 2000)
advance medical directives Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes.
There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions.
Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society).
(12 Mar 2000)
medical directives, advance Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for health-care decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (this entry is based upon material from the national ms society).
(12 Dec 1998)
directives, advance medical Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for health-care decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society).
(12 Dec 1998)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
acceleration phase <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes.
After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase).
(15 Jan 1998)
acute-phase protein <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor).
Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold.
Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability.
These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers.
See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity.
(25 Jun 1999)
acute-phase reaction <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms.
It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors.
(12 Jul 2000)
anal phase In psychoanalytic personality theory, the stage of psychosexual development, occurring when a child is between 1 and 3 years, during which activities, interests, and concerns are centreed around the anal zone.
(05 Mar 2000)
aqueous phase The water portion of a system consisting of two liquid phase's, one mainly water, the other a liquid immiscible with water (e.g., benzene, ether).
(05 Mar 2000)
blast phase Refers to advanced chronic myelogenous leukaemia. In this phase, the number of immature, abnormal white blood cells in the bone marrow and blood is extremely high. Also called blast crisis.
(12 Dec 1998)
g0 phase Phase of the cell cycle where cells exist in a quiescent state. These cells have unduplicated DNA, degraded RNA and protein, and low enzyme activity. The ability to switch between g0 and g1 (and vice versa) determines the post-embryonic cell proliferation rate and is defectively controlled in neoplastic cells.
(12 Dec 1998)
g1 phase <cell biology, molecular biology> The period during interphase in the cell cycle between mitosis and the S phase (when DNA is replicated).
Also known as the decision period of the cell, because the cell decides to divide when it enters the s phase. The G stands for gap.
(09 Oct 1997)
g2 phase <cell biology, molecular biology> The period during interphase in the cell cycle between the S phase (when DNA is replicated) and mitosis (when the nucleus, then cell, divides).
at this time, the cell checks the accuracy of DNA replication and prepares for mitosis. The G stands for gap.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advance
    ³ª¾Æ°¡´Ù,ÀüÁø,Áøº¸,½ÂÁø
  • advance
    ³ª¾Æ°¡°Ô ÇÏ´Ù;½ÂÁø½ÃŰ´Ù;°ªÀ» ¿Ã¸®´Ù;ÀǰßÀ» ³»´Ù ¼±ºÒÇÏ´Ù
  • color phase
    À¯Àü¿¡ ÀÇÇÑ Ã¼»ö º¯È­;°èÀý¿¡ µû¸¥ ¸ðÀÇÀÇ º¯È­»ö
  • phase
    º¯È­;¹ß´ÞÀÇ ´Ü°è;Çü¼¼;±¹¸é;¸é;»ó;À§»óÀ¸·Î ³ª´©´Ù
  • phase angle
    À§»ó°¢
  • phase contrast
    À§»óÂ÷
  • phase microscope
    À§»óÂ÷ Çö¹Ì°æ
  • phase modulation
    À§»ó º¯Á¶
  • phase zero
    (°èȹ µîÀÇ) Áغñ ´Ü°è;Á¦·Î ´Ü°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á